On the other hand, western blotting and immunohistochemistry analyses indicated decreased PTPRD and increased pSTAT3 expression in samples from PTPRD shRNA-transfected breast cancer cells, compared with NC shRNA controls (Figures 5C-5E). This evidence concerns the gene PTPRD and breast carcinoma.